GKOS Latest Headlines

Stifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS)

at www.tipranks.com (Wed, 10-Jun 9:16 AM)

Glaukos: Buy Rating Reiterated on Robust Pipeline and Multi-Product Growth Drivers; $162 Price Target Unchanged

at www.tipranks.com (Wed, 10-Jun 6:15 AM)

Analyst Reiterates Buy on Glaukos, Maintains $136 Price Target Amid Stable LCD Outlook and Long-Term Growth Potential

at www.tipranks.com (Wed, 10-Jun 6:15 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE), Dexcom (DXCM) and Glaukos (GKOS)

at www.tipranks.com (Mon, 8-Jun 5:20 AM)

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)

at www.tipranks.com (Sat, 6-Jun 9:40 PM)

Glaukos Delivers Record Q1 2026 Sales and Raises Full-Year Guidance on Glaucoma Division Strength

Market Chameleon (Thu, 30-Apr 11:54 AM)

Glaukos Launches Epioxa: First FDA-Approved Incision-Free Topical Therapy for Keratoconus is Now Commercially Available

Market Chameleon (Fri, 20-Mar 10:28 AM)

Glaukos Launches Epioxa: First FDA-Approved Topical Drug for Keratoconus Ushers in Transformative Eye Care

Market Chameleon (Thu, 19-Mar 9:06 AM)